Investing Profile

Kristina Burow

VCInvestor
Managing Director at ARCH Venture Partners
Photo of Kristina Burow, Managing Director at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of California, Berkeley Network
362 CONNECTIONS
The University of Chicago Booth School of Business Network
82 CONNECTIONS
cb
ARCH Venture Partners Managing Director
$50K - $150.0M
$50K
34
$635.8M
CompanyStageDateRound SizeTotal Raised
Mirador Therapeutics
Series BJan 2026$250M
Series AMar 2024$400M
$650M
Tenvie Therapeutics
Series AJan 2025$200M
$200M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Paul Berns (ARCH Venture Partners), Alaa Halawa (Mubadala)
Metsera
Series BNov 2024$220M
Series AApr 2024$290M
$510M
Co-investors: Brendan Bulik-Sullivan (GV (Google Ventures)), Paul Berns (ARCH Venture Partners), Nimish Shah (Venrock)
Autobahn Therapeutics
Series CJul 2024$100M
Series BJun 2020$76M
$180M
Remix Therapeutics
Series UnknownJan 2024$60M
Series BMay 2022$70M
Series ADec 2020$65M
$210M
Co-investors: Kevin Bitterman (Atlas Venture), Peter Svennilson (The Column Group), Michael Rome (Foresite Capital), Leon Chen (The Column Group)
Magnet Biomedicine
Series ASep 2023$50M
$50M
Orbital Therapeutics
Series AApr 2023$270M
SeedSep 2022
$270M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Carol Suh (ARCH Venture Partners)
Pretzel Therapeutics
Series ASep 2022$73M
$73M
Co-investors: David Schenkein (GV (Google Ventures)), Jay Parrish (ARCH Venture Partners), Reetika Bhardwaj (ARCH Venture Partners), Alaa Halawa (Mubadala)
Managing Director ARCH Venture PartnersPresent
The University of Chicago Booth School of Business MBA
University of California, Berkeley